| Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study RM Grant, PL Anderson, V McMahan, A Liu, KR Amico, M Mehrotra, ... The Lancet infectious diseases 14 (9), 820-829, 2014 | 1279 | 2014 |
| HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial T Liegler, M Abdel-Mohsen, LG Bentley, R Atchison, T Schmidt, J Javier, ... The Journal of infectious diseases 210 (8), 1217-1227, 2014 | 95 | 2014 |
| Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study A Liu, DV Glidden, PL Anderson, KR Amico, V McMahan, M Mehrotra, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 67 (5), 528-537, 2014 | 83 | 2014 |
| Skating on thin ice: stimulant use and sub‐optimal adherence to HIV pre‐exposure prophylaxis JC Hojilla, D Vlahov, DV Glidden, KR Amico, M Mehrotra, R Hance, ... African Journal of Reproduction and Gynaecological Endoscopy 21 (3), 2018 | 59 | 2018 |
| Depression and oral FTC/TDF pre-exposure prophylaxis (PrEP) among men and transgender women who have sex with men (MSM/TGW) PA Defechereux, M Mehrotra, AY Liu, VM McMahan, DV Glidden, ... AIDS and Behavior 20 (7), 1478-1488, 2016 | 52 | 2016 |
| The effect of depressive symptoms on adherence to daily oral PrEP in men who have sex with men and transgender women: a marginal structural model analysis of the iPrEx OLE study ML Mehrotra, DV Glidden, V McMahan, KR Amico, S Hosek, ... AIDS and Behavior 20, 1527-1534, 2016 | 50 | 2016 |
| Self-reported recent PrEP dosing and drug detection in an open label PrEP study KR Amico, M Mehrotra, VI Avelino-Silva, V McMahan, VG Veloso, ... AIDS and Behavior 20, 1535-1540, 2016 | 44 | 2016 |
| Low tenofovir level in urine by a novel immunoassay is associated with seroconversion in a preexposure prophylaxis demonstration project MA Spinelli, DV Glidden, WC Rodrigues, G Wang, M Vincent, H Okochi, ... Aids 33 (5), 867-872, 2019 | 37 | 2019 |
| The role of social relationships in PrEP uptake and use among transgender women and men who have sex with men ML Mehrotra, K Rivet Amico, V McMahan, DV Glidden, P Defechereux, ... AIDS and Behavior 22, 3673-3680, 2018 | 37 | 2018 |
| Results of the iPrEx open-label extension (iPrEx OLE) in men and transgender women who have sex with men: PrEP uptake, sexual practices, and HIV incidence RM Grant, PL Anderson, V McMahan, A Liu, K Amico, M Mehrotra AIDS, 20-25, 2014 | 30 | 2014 |
| Generalizability of findings from a clinical sample to a community‐based sample: a comparison of ADNI and ARIC KZ Gianattasio, EE Bennett, J Wei, ML Mehrotra, T Mosley, RF Gottesman, ... Alzheimer's & Dementia 17 (8), 1265-1276, 2021 | 25 | 2021 |
| An observational study of preexposure prophylaxis uptake, sexual practices, and HIV incidence among men and transgender women who have sex with men RM Grant, PL Anderson, V McMahan, A Liu, KR Amico, M Mehrotra, ... The Lancet. Infectious diseases 14 (9), 820, 2014 | 24 | 2014 |
| Severe acute respiratory syndrome coronavirus 2 seroprevalence and reported coronavirus disease 2019 cases in US children, August 2020–May 2021 A Couture, BC Lyons, ML Mehrotra, L Sosa, N Ezike, FS Ahmed, ... Open forum infectious diseases 9 (3), ofac044, 2022 | 23 | 2022 |
| Pre-exposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine and kidney tubular dysfunction in HIV-uninfected individuals V Jotwani, R Scherzer, DV Glidden, M Mehrotra, P Defechereux, A Liu, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 78 (2), 169-174, 2018 | 23 | 2018 |
| Brief report: cocaine use and pre-exposure prophylaxis: adherence, care engagement, and kidney function JC Hojilla, DD Satre, DV Glidden, VM McMahan, M Gandhi, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 81 (1), 78-82, 2019 | 21 | 2019 |
| SARS-CoV-2 cumulative incidence and period seroprevalence: results from a statewide population-based serosurvey in California K Lamba, H Bradley, K Shioda, PS Sullivan, N Luisi, EW Hall, ... Open Forum Infectious Diseases 8 (8), ofab379, 2021 | 20 | 2021 |
| Baseline characteristics explain differences in effectiveness of randomization to daily oral TDF/FTC PrEP between transgender women and cisgender men who have sex with men in … ML Mehrotra, D Westreich, VM McMahan, MM Glymour, E Geng, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 81 (3), e94-e98, 2019 | 20 | 2019 |
| Persistent HIV Type 1 Seronegative Status Is Associated With Lower CD8+ T-Cell Activation PJ Kuebler, ML Mehrotra, BI Shaw, KS Leadabrand, JM Milush, VA York, ... The Journal of infectious diseases 213 (4), 569-573, 2016 | 19 | 2016 |
| HIV preexposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine and changes in kidney function and tubular health SB Ascher, R Scherzer, MM Estrella, J Shigenaga, KA Spaulding, ... Aids 34 (5), 699-706, 2020 | 16 | 2020 |
| Understanding HIV program effects: a structural approach to context using the transportability framework ML Mehrotra, ML Petersen, EH Geng JAIDS Journal of Acquired Immune Deficiency Syndromes 82, S199-S205, 2019 | 16 | 2019 |
